Question 1

Has Andrew Leader Cramer received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $1,609 in general payments to Andrew Leader Cramer across 84 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Andrew Leader Cramer did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Andrew Leader Cramer come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Novartis	21	$326
AbbVie(2 entities)	7	$143
Supernus Pharmaceuticals, Inc.	2	$103
Sanofi	5	$102
GE HealthCare	4	$91
Amgen	3	$77
Acorda Therapeutics, Inc	4	$70
Sunovion Pharmaceuticals Inc.	4	$69
MDD US Operations, LLC	4	$65
EMD Serono, Inc.	2	$63
Lilly USA, LLC	3	$53
Grifols USA, LLC	2	$47
Amneal Pharmaceuticals LLC	3	$42
Kyowa Kirin, Inc.	2	$40
UCB, Inc.	2	$38
Tanabe Pharma America, Inc.	2	$37
Acadia Pharmaceuticals Inc	2	$36
Vertical Pharmaceuticals, LLC	2	$35
Genentech USA, Inc.	2	$34
Avanir Pharmaceuticals, Inc.	2	$34
Greenwich Biosciences, Inc.	1	$25
Strongbridge US Inc.	1	$19
Biogen	1	$18
Teva Pharmaceuticals USA, Inc.	1	$16
Ipsen Biopharmaceuticals, Inc	1	$14
Shire North American Group Inc	1	$12

Andrew Leader Cramer

Payments from drug & device makers

Who reported the general payments

How this compares

Other neurology in Peabody